Nutrition management of infants with surgical short bowel syndrome and intestinal failure.

Item

http://www.wikidata.org/entity/Q38114043

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nutrition management of infant ...... ndrome and intestinal failure.

@en

type

Item

label

Nutrition management of infant ...... ndrome and intestinal failure.

@en

prefLabel

Nutrition management of infant ...... ndrome and intestinal failure.

@en

P1476

Nutrition management of infant ...... ndrome and intestinal failure.

@en

P2093

Conrad R Cole

http://www.w3.org/2001/XMLSchema#string

Samuel A Kocoshis

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics

Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.

Interactions between nutrients and peptide growth factors in intestinal growth, repair, and function.

The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses.

Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2.

Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.

Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel.

Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

P304

421-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0884533613491787

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23761561

http://www.w3.org/2001/XMLSchema#string